MeSH tree: E05.318
A routine heart scan might soon do more than just check for clogged arteries; it could act as a crystal ball for your cardiac health. Researchers at Kumamoto University have revealed that by combining two specific markers ...
Apr 22, 2026
0
7
Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index. By identifying patients ...
Apr 22, 2026
0
1
In an increasingly digital world, millions of disabled people are being systematically excluded from critical services every day, from their medical records to bank accounts to emergency response systems. These services are ...
Apr 22, 2026
0
1
Researchers at McMaster University have identified, for the first time, a novel region of DNA and two associated genes connected to frailty, offering neurological and immune-related insights that might help explain why some ...
Apr 22, 2026
0
6
Older men with prostate cancer who receive federal housing assistance at the time they are first diagnosed have better two-year survival chances compared to demographically and clinically similar men without that assistance, ...
Apr 21, 2026
0
2
For most of the 20th century, cardiovascular disease (CVD) was perceived to be a predominantly male condition, leading to systematic under-recognition and under-treatment in women. Since its inception in 1948, the Framingham ...
Apr 21, 2026
0
5
Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to a reduction in lesion size and allowed some patients to avoid surgery, according to research from a Phase I clinical trial presented at the American ...
Apr 21, 2026
0
12
An Australia-wide study led by researchers at Adelaide University has found ketamine consumption is increasing across the country. The study analyzed wastewater samples collected between December 2020 and April 2025. Daily ...
Apr 20, 2026
0
2
Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly concentrated at the top 20 ...
Apr 20, 2026
0
1
The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D ...
Apr 20, 2026
0
3
